2.6. Cell-based Spike-ACE2 inhibition assay

MT Masaru Takeshita
NN Naoshi Nishina
SM Saya Moriyama
YT Yoshimasa Takahashi
YU Yoshifumi Uwamino
MN Mika Nagata
WA Wataru Aoki
KM Katsunori Masaki
MI Makoto Ishii
HS Hideyuki Saya
YK Yasushi Kondo
YK Yuko Kaneko
KS Katsuya Suzuki
KF Koichi Fukunaga
TT Tsutomu Takeuchi
request Request a Protocol
ask Ask a question
Favorite

The expression vectors (12 μg of full-length spike protein and 6 μg of pMX-GFP) were cotransfected into 293T cells on 100 mm dish using 43.2 μg of Polyethylenimine Max (Polyscience, PA, USA). After two days, cells were washed with PBS supplemented with 0.5% BSA and 2 mM EDTA (staining buffer), incubated with diluted serum samples for 20 min at 4 °C, washed again, and incubated with premixed ACE2-SBP and APC-conjugated streptavidin (0.6 μg/ml and 0.4 μg/ml, respectively) for 20 min at 4 °C. After the final wash, the cells were analyzed by a FACS Verse. The MFI among GFP+ cells was calculated using FlowJo (BD) and used as an indicator of Spike-ACE2 binding. Cells without serum and without ACE2-SBP were used as negative and positive controls, respectively. The representative plots are shown in Supplementary Fig. 1D. The measurement procedures are illustrated in Fig. 1C.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A